Fewer Benzos Prescribed to Kids; Teva Liable for Opioid Crisis; Food Addictions?

New stimulant and anxiolytic/sedative-hypnotic use among Canadian children took a significant nosedive during the COVID-19 pandemic. On the other hand, new antidepressant use among kids rose by the end of 2020 — passing pre-pandemic levels. (JAMA Pediatrics)

Depression was tied to an increased risk for new-onset atrial fibrillation in a South Korean cohort of over 5 million adults. (JAMA Network Open)

A New York state jury found Teva Pharmaceuticals liable for its hand in the opioid crisis. (The New York Times)

In related news, could restrictions and regulations on virtual opioid use disorder treatment soon hinder care? (NPR)

Over in England, rates of eating disorder-related hospital admissions among kids has spiked so much this past year that the NHS can no longer treat every case. (The Guardian)

Is the obesity epidemic really just an addiction to food? (The Hill)

The mental health platform Total Brain said it will license its International Study to Predict Optimized Treatment for Depression (iSPOT-D) research data to Alto Neuroscience to use in the development of its depression products.

The University of North Carolina was awarded a 5-year, $3.9-million grant to study the effects of estradiol on reward circuitry functioning in a transdiagnostic sample of women with perimenopausal-onset anhedonia and psychosis.

Please enable JavaScript to view the comments powered by Disqus.